EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy

Guohao Wang, Dongmei Wang, Lu Xia, Jiabian Lian, Qing Zhang, Dongyan Shen, Zhanxiang Wang, Yunlu Dai iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.4c21028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Guohao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen Cell Therapy Research Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China. Hauptthemen laut MEDLINE: Fatty Acids, Neoplasms, Coordination Complexes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de Macau, Natural Science Foundation of Xiamen Municipality, Fujian Provincial Health Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty AcidsNeoplasmsCoordination ComplexesAnimalsMiceFemaleCell Line, TumorNanomedicineMice, Inbred BALB CNanoparticlesHumansTungstenPolyphenolsReactive Oxygen SpeciesMetabolic Reprogramming

Stichwörter der Autor:innen

cancer radiotherapyfatty acidimmunotherapymetal−phenolic networksradiosensitizer

Substanzen

Fatty AcidsTungstenPolyphenolsReactive Oxygen SpeciesCoordination Complexes

Autor:innen und Institutionen

  • Xiamen Cell Therapy Research Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
  • Department of Public Health and Medical Technology, Xiamen Medical College, Xiamen 361023, China.
  • Center for Precision Medicine, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen361000, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen361000, China.
  • Department of Cardiology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
  • Department of Neurosurgery and Department of Neuroscience, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, Xiamen Key Laboratory of Brain Center, the First Affiliated Hospital of Xiamen Universi…

ORCID-Profile: Yunlu Dai

Förderung

  • Universidade de Macau
  • Natural Science Foundation of Xiamen Municipality
  • Fujian Provincial Health Technology Project
  • Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia
  • National Natural Science Foundation of China
  • Xiamen Cell Therapy Research Center
  • Xiamen City

Zitieren

APA

Wang, G., Wang, D., Xia, L., Lian, J., Zhang, Q., Shen, D., Wang, Z., & Dai, Y. (2025). Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c21028

Vancouver

Wang G, Wang D, Xia L, Lian J, Zhang Q, Shen D, et al. Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c21028

BibTeX
@article{Wang2025,
  author = {Wang, Guohao and Wang, Dongmei and Xia, Lu and Lian, Jiabian and Zhang, Qing and Shen, Dongyan and Wang, Zhanxiang and Dai, Yunlu},
  title = {Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.4c21028}
}
Kostenlos starten →